Evidence map›Paper›PMID 35774042›Full record

ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2022

'Intel Acat' Assistive Platform for Arabic Speaking Disabled People: a Complete Integration.

Ahmed Zakariya Nadji, Rachid Boudour

Abstract read
In one paragraph

Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ahmed Zakariya NadjiEmbedded Systems Laboratory, Department of Computer Science, University of Badji Mokhtar, Annaba, Algeria.
Rachid BoudourEmbedded Systems Laboratory, Department of Computer Science, University of Badji Mokhtar, Annaba, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Intel Assistive Context-Aware Toolkit (ACAT) is the highly configurable platform used by Dr. Stephen Hawking to communicate with his environment. After being released freely to the public, we, at the Embedded Systems Laboratory - UBMA, have been working on integrating the Arabic language on the different packages of the platform in order to make it accessible for disabled people from Arabic countries and decrease their communication limitations. Objective: This subproject concerns the Arabic Text-to-speech engine implementation and comes as a final step toward the full integration of the Arabic language into Intel ACAT assistive platform. Methods: The text to speech conversions was integrated by implementing a mapping between the Arabic words and their phonetic spelling using Microsoft Text-To-Speech Synthesis on Intel ACAT modules and extensions. A full compilation was then executed and tested gathering all the modules and the features of the platform. Results: Over this final integration step (which is freely accessible and open sourced for the public), people with severe disabilities from Arabic-speaking countries will have fully access to all the features of the ACAT platform and will be able communicate and interact easily with their computers. Conclusion: The Arabic language Text-to-speech engine integration on 'Intel ACAT' Assistive Platform is the final milestone of our project toward making the platform fully accessible for Arabic-Speaking users and comes after our previous integrations of the Arabic language into the keyboard, the intelligent predictive text engine and all panels and interfaces of the platform.

Indexed as

LanguagePhoneticsHumansArabic languageAssistive platformDigital DivideIntel ACATPeople with disabilities

Identifiers

PMID35774042
PMCPMC9233464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.